FMTC
ABBV icon

Farmers & Merchants Trust Company’s AbbVie ABBV Stock Holding History

Farmers & Merchants Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
7,063
+34
+0.5% +$7.54K 0.36% 56
2025
Q4 		$1.61M Buy
7,029
+1,002
+17% +$228K 0.37% 53
2025
Q3 		$1.4M Sell
6,027
-11,075
-65% -$2.26M 0.29% 61
2025
Q2 		$3.17M Buy
17,102
+11,484
+204% +$2.13M 0.67% 32
2025
Q1 		$1.18M Buy
5,618
+1,376
+32% +$268K 0.3% 62
2024
Q4 		$754K Buy
4,242
+217
+5% +$39.9K 0.19% 89
2024
Q3 		$795K Buy
4,025
+70
+2% +$13.1K 0.2% 86
2024
Q2 		$678K Sell
3,955
-3,758
-49% -$623K 0.18% 97
2024
Q1 		$1.4M Sell
7,713
-1,853
-19% -$319K 0.35% 60
2023
Q4 		$1.48M Sell
9,566
-144
-1% -$21K 0.39% 52
2023
Q3 		$1.45M Sell
9,710
-42
-0.4% -$6.17K 0.43% 52
2023
Q2 		$1.31M Sell
9,752
-251
-3% -$36.8K 0.35% 58
2023
Q1 		$1.59M Sell
10,003
-109
-1% -$16.7K 0.44% 46
2022
Q4 		$1.63M Buy
10,112
+955
+10% +$146K 0.46% 46
2022
Q3 		$1.23M Buy
9,157
+393
+4% +$56.4K 0.38% 54
2022
Q2 		$1.34M Buy
8,764
+19
+0.2% +$2.9K 0.41% 51
2022
Q1 		$1.42M Sell
8,745
-578
-6% -$84K 0.37% 52
2021
Q4 		$1.26M Sell
9,323
-205
-2% -$24.2K 0.31% 58
2021
Q3 		$1.03M Sell
9,528
-270
-3% -$30.9K 0.27% 67
2021
Q2 		$1.1M Sell
9,798
-44
-0.4% -$4.96K 0.3% 62
2021
Q1 		$1.06M Sell
9,842
-264
-3% -$28.2K 0.36% 59
2020
Q4 		$1.08M Sell
10,106
-114
-1% -$11K 0.4% 51
2020
Q3 		$895K Hold
10,220
– – 0.37% 59
2020
Q2 		$1M Buy
10,220
+196
+2% +$17.3K 0.45% 48
2020
Q1 		$764K Hold
10,024
– – 0.41% 55
2019
Q4 		$888K Buy
10,024
+280
+3% +$23.2K 0.37% 57
2019
Q3 		$738K Sell
9,744
-992
-9% -$68K 0.32% 68
2019
Q2 		$780K Sell
10,736
-138
-1% -$10.8K 0.35% 63
2019
Q1 		$877K Sell
10,874
-2,067
-16% -$169K 0.4% 59
2018
Q4 		$1.19M Buy
+12,941
New +$1.14M 0.6% 39

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Farmers & Merchants Trust Company's ABBV Position: Q1 2026 in Review

Farmers & Merchants Trust Company increased its AbbVie (ABBV) stake by 0.48% in Q1 2026, buying an estimated $7.54K and bringing the position to 7,063 shares worth $1.54M. The position accounts for 0.36% of the portfolio, ranked #56.

Farmers & Merchants Trust Company first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.17M in Q2 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Farmers & Merchants Trust Company held 7,063 shares of AbbVie worth $1.54M as of Q1 2026.
  • Farmers & Merchants Trust Company bought 34 AbbVie shares in Q1 2026, an estimated $7.54K.
  • AbbVie made up 0.36% of Farmers & Merchants Trust Company's portfolio in Q1 2026, its #56 holding.
  • Farmers & Merchants Trust Company first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
  • Farmers & Merchants Trust Company's AbbVie position peaked at $3.17M in Q2 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Farmers & Merchants Trust Company's 13F filing for Q1 2026, filed 16 Apr 2026.